DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
LBH589
Panobinostat
Panobinostat (LBH-589) is an experimental drug developed by Novartis for the treatment of various cancers. It is a hydroxamic acid and acts as a non-selective HDAC inhibitor.
LBH589 - List of case studies
- IgG Multiple Myeloma
-
histone deacetylase inhibitors such as LAQ824 and LBH589 as well as tubacin , and vorinostat ; the PI3K/AKT inhibitor ... pomalidomide, histone deacetylase inhibitors, LAQ824, LBH589, tubacin, vorinostat, PI3K/AKT inhibitor, perifosine, heat shock protein ...
- Drugs
-
L L-leucovorin LAQ824 LASIX LBH589 LHRH agonist LHRH-A LIMPIDEX Labelled somatostatin ...